Dihydrocapsaicin

Dihydrocapsaicin at a Glance

Dihydrocapsaicin is the second major capsaicinoid of pungent Capsicum fruit, and the structural twin of capsaicin: the two molecules are identical except that capsaicin’s acyl tail carries a double bond (8-methyl-N-vanillyl-6-nonenamide) and dihydrocapsaicin’s does not (8-methyl-N-vanillylnonanamide) ^{11Reference 11Kuzma M et al. · 2015AnimalA validated HPLC-FLD method for analysis of intestinal absorption and metabolism of capsaicin and dihydrocapsaicin in the ratView study →}. One saturated bond, two mass units — 307 versus 305 Da — and otherwise the same vanillyl “warhead” that opens the TRPV1 ion channel ^{3Reference 3Antonious GF · 2006Screening Capsicum accessions for capsaicinoids contentView study →}.

That near-identity is the whole story, in two directions. Practically, it means dihydrocapsaicin is a co-driver of chilli heat, not a trace companion: in oleoresin capsicum, capsaicin and dihydrocapsaicin are the two analogues primarily responsible for pungency, and pungency tracks total capsaicinoid content rather than capsaicin alone ^{2,5Reference 2Reilly CA et al. · 2001Quantitative analysis of capsaicinoids in fresh peppers, oleoresin capsicum and pepper spray productsView study →Reference 5Govindarajan VS et al. · 1987ReviewCapsicum — production, technology, chemistry, and qualityView study →}. Scientifically, it means a great deal of published work nominally “about capsaicin” was done on pepper extracts that are capsaicin/dihydrocapsaicin mixtures — a point made explicitly by the pharmaceutical group that had to run the pure molecule to characterise it properly ^{9Reference 9Chanda S et al. · 2008In vitroIn vitro hepatic and skin metabolism of capsaicinView study →}.

Where dihydrocapsaicin does have its own literature, it is preclinical and it is dominated by an unexpected niche: it is the TRPV1 agonist of choice for pharmacological hypothermia in rodent stroke and cardiac-arrest models ^{15,16,18,19Reference 15Cao Z et al. · 2014AnimalPharmacologically induced hypothermia via TRPV1 channel agonism provides neuroprotection following ischemic stroke when initiated 90 min after reperfusion (mice)View study →Reference 16Feketa VV et al. · 2014AnimalTransient receptor potential melastatin 8 channel inhibition potentiates the hypothermic response to transient receptor potential vanilloid 1 activation in the conscious mouseView study →Reference 18Cao Z et al. · 2017AnimalTRPV1-mediated pharmacological hypothermia promotes improved functional recovery following ischemic stroke (mice)View study →Reference 19He J et al. · 2016AnimalDihydrocapsaicin-induced hypothermia after asphyxial cardiac arrest in ratsView study →}. Nothing here inherits capsaicin’s clinical record. The 8% capsaicin patch is a capsaicin product; this molecule has no approved human indication.

Dihydrocapsaicin vs. Capsaicin

The comparison is the most useful thing to take away, so it goes first.

Property	Capsaicin	Dihydrocapsaicin
Systematic name	8-methyl-N-vanillyl-trans-6-nonenamide	8-methyl-N-vanillylnonanamide
Acyl tail	one cis/trans double bond at C6	fully saturated
Nominal mass	305 Da (m/z 306 as [M+H]⁺)	307 Da (m/z 308 as [M+H]⁺)
Typical share of total capsaicinoids	usually the larger share (31–71% across cultivars)	usually second (commonly ~20–40%)
Pungency contribution	principal	co-principal
Approved human medicine	yes (topical creams, 8% patch)	none

What is genuinely different. Three head-to-head findings exist, and all three favour dihydrocapsaicin being more, not less, active in the specific assay run:

• In cancer cell lines, dihydrocapsaicin was more cytotoxic than capsaicin in HCT116 colorectal, MCF-7 breast and WI38 fibroblast cells, and acted primarily by inducing autophagy rather than apoptosis ^{24Reference 24Oh SH et al. · 2008In vitroDihydrocapsaicin (DHC), a saturated structural analog of capsaicin, induces autophagy in human cancer cells in a catalase-regulated manner (in vitro)View study →}.
• Given subcutaneously to rats at 3 mg/kg/day for ten days, dihydrocapsaicin raised plasma glucose, free fatty acids and glycerol faster and to a greater degree than capsaicin at the same dose; capsaicin’s lipolytic effect appeared only from day 7 ^{21Reference 21Imaizumi K et al. · 2011AnimalCapsaicinoids-induced changes of plasma glucose, free fatty acid and glycerol concentrations in ratsView study →}.
• In the rodent hypothermia literature, dihydrocapsaicin — not capsaicin — is the compound repeatedly chosen for systemic TRPV1 agonism, and its hypothermic effect is dose-dependent, reproducible on repeat dosing, and abolished in TRPV1-knockout mice ^{15,16Reference 15Cao Z et al. · 2014AnimalPharmacologically induced hypothermia via TRPV1 channel agonism provides neuroprotection following ischemic stroke when initiated 90 min after reperfusion (mice)View study →Reference 16Feketa VV et al. · 2014AnimalTransient receptor potential melastatin 8 channel inhibition potentiates the hypothermic response to transient receptor potential vanilloid 1 activation in the conscious mouseView study →}.

What is not established. There is no clean published head-to-head TRPV1 EC₅₀ or human sensory-threshold comparison in the sources surveyed here. The two are conventionally treated as similarly pungent when total-capsaicinoid HPLC data are converted to Scoville heat units ^{1,5Reference 1Duelund L · 2017Contents of capsaicinoids in chillies grown in DenmarkView study →Reference 5Govindarajan VS et al. · 1987ReviewCapsicum — production, technology, chemistry, and qualityView study →} — a convention rather than a demonstrated equivalence, and one worth holding loosely.

Why the mixture problem matters. Pepper extracts are, by nature, mixtures of capsaicin, dihydrocapsaicin, nordihydrocapsaicin, homocapsaicin and homodihydrocapsaicin ^{9Reference 9Chanda S et al. · 2008In vitroIn vitro hepatic and skin metabolism of capsaicinView study →}. Analytical methods developed for skin and plasma work quantify capsaicin and dihydrocapsaicin simultaneously, because in practice both are always present ^{11,14Reference 11Kuzma M et al. · 2015AnimalA validated HPLC-FLD method for analysis of intestinal absorption and metabolism of capsaicin and dihydrocapsaicin in the ratView study →Reference 14Lorenzoni R et al. · 2019Rapid and sensitive LC-MS/MS method for simultaneous quantification of capsaicin and dihydrocapsaicin in microdialysis samples following dermal applicationView study →}. When a paper says “capsaicin extract”, assume dihydrocapsaicin was in the vial too.

The Capsaicinoid Profile as a Quality & Chemotaxonomic Marker

The ratio between capsaicinoids is not noise — it is a stable, heritable trait, and it is how the Capsicum genus is fingerprinted.

Across 15 chilli cultivars grown under identical conditions, the relative distribution of the four major capsaicinoids was highly variable between cultivars, with capsaicin ranging from 31% to 71% of the total ^{1Reference 1Duelund L · 2017Contents of capsaicinoids in chillies grown in DenmarkView study →}. Within a single plant, the picture inverts: individual fruits harvested at the same time differ enormously in absolute capsaicinoid content, yet the ratio of capsaicin to dihydrocapsaicin to nordihydrocapsaicin stays rather uniform ^{4Reference 4Kirschbaum-Titze P et al. · 2002Pungency in paprika (Capsicum annuum)View study →}. Absolute pungency is environmental; the profile is genetic.

Genetics bears that out. Segregation analysis of an interspecific C. annuum × C. frutescens cross mapped six QTL controlling capsaicinoid content across three chromosomes, with capsaicin, dihydrocapsaicin and nordihydrocapsaicin analysed as separate traits and a branched-chain aminotransferase gene co-localising with one QTL ^{6Reference 6Ben-Chaim A et al. · 2006QTL analysis for capsaicinoid content in CapsicumView study →}. Screening 90 accessions from the USDA germplasm collection across five Capsicum species found capsaicin usually the dominant capsaicinoid but with clear exceptions — the highest dihydrocapsaicin accession was a C. frutescens line at 2.3 mg/g fresh fruit, while the highest capsaicin accession was a different, C. chinense line ^{3Reference 3Antonious GF · 2006Screening Capsicum accessions for capsaicinoids contentView study →}.

Two practical consequences follow. First, standardised chilli products are measured as total capsaicinoids, not capsaicin — including pepper sprays, whose potency has been shown to vary between manufacturers and even between lots from the same manufacturer despite an SHU label ^{2Reference 2Reilly CA et al. · 2001Quantitative analysis of capsaicinoids in fresh peppers, oleoresin capsicum and pepper spray productsView study →}. Second, the capsaicin:dihydrocapsaicin ratio is a usable authenticity and chemotype marker for identifying which species or cultivar an oleoresin came from.

What It's Used For

Dihydrocapsaicin’s evidence base is preclinical and unevenly distributed. One application — TRPV1-mediated pharmacological hypothermia — has a genuinely dihydrocapsaicin-specific, mechanistically controlled rodent literature. The rest is either shared with capsaicin as a class effect or is single-laboratory cell work.

Evidence by IndicationStrength of support · Beta

Support is an experimental score — weighted by study type (human > animal > in vitro) and volume. A beta, not a validated metric. Note that no row here rests on a human trial of the isolated molecule; the ceiling is low by design.

01Pharmacological Hypothermia & NeuroprotectionShaky42%Multiple independent rodent studies, dose–response, TRPV1-knockout controls ^{15,16,17,18,19Reference 15Cao Z et al. · 2014AnimalPharmacologically induced hypothermia via TRPV1 channel agonism provides neuroprotection following ischemic stroke when initiated 90 min after reperfusion (mice)View study →Reference 16Feketa VV et al. · 2014AnimalTransient receptor potential melastatin 8 channel inhibition potentiates the hypothermic response to transient receptor potential vanilloid 1 activation in the conscious mouseView study →Reference 17Feketa VV et al. · 2013AnimalShivering and tachycardic responses to external cooling in mice are substantially suppressed by TRPV1 activation but not by TRPM8 inhibitionView study →Reference 18Cao Z et al. · 2017AnimalTRPV1-mediated pharmacological hypothermia promotes improved functional recovery following ischemic stroke (mice)View study →Reference 19He J et al. · 2016AnimalDihydrocapsaicin-induced hypothermia after asphyxial cardiac arrest in ratsView study →}

02Thermogenesis & Metabolic EffectsShaky32%Human meta-analyses of capsaicinoid mixtures; one isolate-level rat comparison ^{21,22,23Reference 21Imaizumi K et al. · 2011AnimalCapsaicinoids-induced changes of plasma glucose, free fatty acid and glycerol concentrations in ratsView study →Reference 22Irandoost P et al. · 2021Meta-analysisThe effect of capsaicinoids or capsinoids in red pepper on thermogenesis in healthy adults: a systematic review and meta-analysisView study →Reference 23Zsiborás C et al. · 2018Meta-analysisCapsaicin and capsiate could be appropriate agents for treatment of obesity: a meta-analysis of human studiesView study →}

03Anticancer Activity (Preclinical)Shaky24%Cell lines + one xenograft model; a head-to-head cytotoxicity edge over capsaicin ^{24,25,26Reference 24Oh SH et al. · 2008In vitroDihydrocapsaicin (DHC), a saturated structural analog of capsaicin, induces autophagy in human cancer cells in a catalase-regulated manner (in vitro)View study →Reference 25Xie L et al. · 2016In vitroCapsaicin and dihydrocapsaicin induce apoptosis in human glioma cells via ROS and Ca²⁺-mediated mitochondrial pathway (in vitro)View study →Reference 26Shi S et al. · 2021AnimalDihydrocapsaicin inhibits cell proliferation and metastasis in melanoma via down-regulating β-catenin pathway (mice)View study →}

04Cardiovascular & Cardioprotective EffectsShaky18%Single rodent MI study with target identification; class-level review ^{27,29Reference 27Chen Y et al. · 2025AnimalDihydrocapsaicin attenuates oxidative stress and apoptosis in acute myocardial infarction via promoting Raf-1/ASK1 complex formation (rats)View study →Reference 29Mandal SK et al. · 2023ReviewCapsicum annuum L. and its bioactive constituents: a critical review of a traditional culinary spice in terms of its modern pharmacological potentials with toxicological issuesView study →}

05Topical Analgesia (Capsaicinoid Class)Shaky15%Class membership and shared TRPV1 mechanism only — the clinical record is capsaicin’s ^{9,14Reference 9Chanda S et al. · 2008In vitroIn vitro hepatic and skin metabolism of capsaicinView study →Reference 14Lorenzoni R et al. · 2019Rapid and sensitive LC-MS/MS method for simultaneous quantification of capsaicin and dihydrocapsaicin in microdialysis samples following dermal applicationView study →}

Mechanisms

The load-bearing line is the third one. Systemic TRPV1 agonism does not simply “burn calories” — in a controlled rodent preparation it shuts BAT thermogenesis down.

Pharmacokinetics

Dihydrocapsaicin’s PK is unusually well described because it was the tracer: the classic capsaicinoid absorption study used tritiated dihydrocapsaicin, not capsaicin ^{10Reference 10Donnerer J et al. · 1990AnimalAbsorption and metabolism of capsaicinoids following intragastric administration in ratsView study →}. Given intragastrically to rats, [³H]-dihydrocapsaicin was readily absorbed but almost completely metabolised before reaching the systemic circulation — biotransformation began in the intestinal lumen itself, unchanged compound was detectable in portal-vein blood, and less than 5% of extracted radioactivity in trunk blood and brain was unchanged parent 15 minutes after gastrointestinal dosing. By contrast, roughly 50% was unchanged 3 minutes after intravenous or 90 minutes after subcutaneous administration — a first-pass effect so complete that route determines whether the molecule has systemic pharmacology at all. The metabolites showed no capsaicin-like activity, and liver (not brain) tissue performed the conversion ^{10Reference 10Donnerer J et al. · 1990AnimalAbsorption and metabolism of capsaicinoids following intragastric administration in ratsView study →}. Intestinal perfusion work in rats confirms glucuronidation of both capsaicin and dihydrocapsaicin during absorption ^{11Reference 11Kuzma M et al. · 2015AnimalA validated HPLC-FLD method for analysis of intestinal absorption and metabolism of capsaicin and dihydrocapsaicin in the ratView study →}.

Hepatically, the characterised oxidative metabolism is capsaicin’s — human, rat and dog microsomes converge on 16-hydroxy-, 17-hydroxy- and 16,17-dehydrocapsaicin, with skin metabolism minimal relative to liver ^{9Reference 9Chanda S et al. · 2008In vitroIn vitro hepatic and skin metabolism of capsaicinView study →}; the equivalent map for dihydrocapsaicin has not been published to the same standard. What is established for dihydrocapsaicin specifically is the enzyme-inhibition side: it moderately inhibits CYP1A2, 2C9, 2C19, 2D6 and 3A4/5 in human liver microsomes (IC₅₀ 4.4–61.8 µM), largely sparing CYP2E1, and repeated dosing in rats induced CYP2E1 ^{12Reference 12Zhang QH et al. · 2012In vitroEffects of capsaicin and dihydrocapsaicin on human and rat liver microsomal CYP450 enzyme activities in vitro and in vivoView study →}. That is not theoretical — pretreating rats with 10 mg/kg/day dihydrocapsaicin for two weeks raised the AUC of the antiretroviral efavirenz roughly 2.5-fold and cut plasma clearance from 6.7 to 2.7 L/h/kg, with the same inhibition reproduced in rat liver microsomes ^{13Reference 13Wang B et al. · 2025In vitroImpact of dihydrocapsaicin on the metabolism of efavirenz in vitro and in vivo (rats)View study →}.

The practical reading: oral dihydrocapsaicin has poor systemic bioavailability and short-lived exposure, which is exactly why the hypothermia literature infuses it subcutaneously or intravenously — and why in-vitro concentrations that kill cancer cells are not plausibly reached by eating chilli.

Clinical Trials

There are no clinical trials of isolated dihydrocapsaicin. Human capsaicinoid trials — thermogenesis, metabolic and exercise studies — administer mixtures, whole chilli or standardised total-capsaicinoid extracts ^{22,23Reference 22Irandoost P et al. · 2021Meta-analysisThe effect of capsaicinoids or capsinoids in red pepper on thermogenesis in healthy adults: a systematic review and meta-analysisView study →Reference 23Zsiborás C et al. · 2018Meta-analysisCapsaicin and capsiate could be appropriate agents for treatment of obesity: a meta-analysis of human studiesView study →}, and the licensed topical products are capsaicin ^{9Reference 9Chanda S et al. · 2008In vitroIn vitro hepatic and skin metabolism of capsaicinView study →}.

Last checked: July 2026.

Thermogenesis vs. Hypothermia — Resolving the Paradox

Two claims sit awkwardly together in the literature above: chilli capsaicinoids modestly increase energy expenditure in humans, and systemic dihydrocapsaicin reliably lowers core temperature in rodents by up to 9 °C. Both are real; they differ in route and dose.

• Dietary route, low systemic exposure. Oral capsaicinoids are largely metabolised before reaching the circulation ^{10Reference 10Donnerer J et al. · 1990AnimalAbsorption and metabolism of capsaicinoids following intragastric administration in ratsView study →}. What the gut sees is a strong local TRPV1 stimulus; the systemic result in human trials is a small rise in resting metabolic rate and fat oxidation, on the order of 34–59 kcal/day and mostly in people with a BMI above 25 ^{22,23Reference 22Irandoost P et al. · 2021Meta-analysisThe effect of capsaicinoids or capsinoids in red pepper on thermogenesis in healthy adults: a systematic review and meta-analysisView study →Reference 23Zsiborás C et al. · 2018Meta-analysisCapsaicin and capsiate could be appropriate agents for treatment of obesity: a meta-analysis of human studiesView study →}.
• Parenteral route, high systemic exposure. Injected or infused, dihydrocapsaicin reaches concentrations that activate central and peripheral thermoregulatory TRPV1 directly. The organism responds as if it were overheating: it sheds heat, stops shivering, and core temperature falls into the therapeutic-hypothermia window ^{16,17Reference 16Feketa VV et al. · 2014AnimalTransient receptor potential melastatin 8 channel inhibition potentiates the hypothermic response to transient receptor potential vanilloid 1 activation in the conscious mouseView study →Reference 17Feketa VV et al. · 2013AnimalShivering and tachycardic responses to external cooling in mice are substantially suppressed by TRPV1 activation but not by TRPM8 inhibitionView study →}. A controlled preparation makes the direction explicit — intravenous dihydrocapsaicin reduced brown-adipose sympathetic nerve activity, BAT temperature and expired CO₂ in rats, and did so by a non-vagal pathway ^{20Reference 20Mohammed M et al. · 2018AnimalActivation of TRPV1 in nucleus tractus solitarius reduces brown adipose tissue thermogenesis, arterial pressure, and heart rate (rats)View study →}.

The upshot: “capsaicinoids are thermogenic” is a statement about dietary exposure and whole-body energy balance, not a claim that TRPV1 agonism raises body temperature. At pharmacological systemic doses the sign flips. This is also the cleanest argument against extrapolating high-dose dihydrocapsaicin animal work to a supplement.

Isolate vs. Plant Studies

This molecule inverts the usual pattern in an instructive way. The animal literature is unusually clean isolate work — the hypothermia, PK and CYP studies all used purified dihydrocapsaicin at stated doses, several with knockout controls ^{10,12,15,16Reference 10Donnerer J et al. · 1990AnimalAbsorption and metabolism of capsaicinoids following intragastric administration in ratsView study →Reference 12Zhang QH et al. · 2012In vitroEffects of capsaicin and dihydrocapsaicin on human and rat liver microsomal CYP450 enzyme activities in vitro and in vivoView study →Reference 15Cao Z et al. · 2014AnimalPharmacologically induced hypothermia via TRPV1 channel agonism provides neuroprotection following ischemic stroke when initiated 90 min after reperfusion (mice)View study →Reference 16Feketa VV et al. · 2014AnimalTransient receptor potential melastatin 8 channel inhibition potentiates the hypothermic response to transient receptor potential vanilloid 1 activation in the conscious mouseView study →}. The human literature is entirely the opposite: not one trial has administered the isolate. Human capsaicinoid studies use chilli, oleoresin or extracts standardised to total capsaicinoids, in which dihydrocapsaicin is present but never the variable ^{22,23Reference 22Irandoost P et al. · 2021Meta-analysisThe effect of capsaicinoids or capsinoids in red pepper on thermogenesis in healthy adults: a systematic review and meta-analysisView study →Reference 23Zsiborás C et al. · 2018Meta-analysisCapsaicin and capsiate could be appropriate agents for treatment of obesity: a meta-analysis of human studiesView study →}.

The deeper transferability problem is upstream of that. Because pepper extracts are inherently mixtures ^{9Reference 9Chanda S et al. · 2008In vitroIn vitro hepatic and skin metabolism of capsaicinView study →}, a large fraction of the historical “capsaicin” literature is really capsaicin-plus-dihydrocapsaicin literature — which cuts both ways. It means dihydrocapsaicin has quietly contributed to results credited to capsaicin, and it means no attribution to either molecule from those studies is secure. Where purity mattered — the development of pharmaceutical-grade capsaicin — investigators had to go back and characterise the pure compound precisely because the published record was mixture-based ^{9Reference 9Chanda S et al. · 2008In vitroIn vitro hepatic and skin metabolism of capsaicinView study →}.

Consequently: treat dihydrocapsaicin’s pungency and TRPV1 agonism as solid, its rodent pharmacology as genuine but preclinical, and any human claim as belonging to the mixture, the whole chilli, or to capsaicin — not to this molecule.

Its Role in Plants

Capsaicinoids are made only by the genus Capsicum, and they are a defence compound aimed at mammals — the classic explanation being that mammalian TRPV1 responds to them while birds, the seed dispersers, do not.

Biosynthetically, capsaicinoids are acid amides of C9–C11 branched-chain fatty acids with vanillylamine ^{8Reference 8Uarrota VG et al. · 2021ReviewFactors affecting the capsaicinoid profile of hot peppers and biological activity of their non-pungent analogs (capsinoids) present in sweet peppersView study →}. Vanillylamine derives from phenylalanine through the phenylpropanoid pathway; the acyl half derives from valine or leucine via branched-chain amino-acid metabolism, and the two halves are condensed in the placental tissue surrounding the seeds, where capsaicinoids accumulate ^{7Reference 7Arce-Rodríguez ML · 2019ReviewBiochemistry and molecular biology of capsaicinoid biosynthesis: recent advances and perspectivesView study →}. Dihydrocapsaicin and capsaicin differ solely in whether the branched-chain acyl partner is saturated — which is why they are always produced together, and why their ratio is a stable genotypic trait rather than an independent variable ^{4,6Reference 4Kirschbaum-Titze P et al. · 2002Pungency in paprika (Capsicum annuum)View study →Reference 6Ben-Chaim A et al. · 2006QTL analysis for capsaicinoid content in CapsicumView study →}.

Pungency is genotype-set but environmentally modulated. Capsaicinoid content rises as fruit matures, varies with node position (second-node fruits accumulate most), and responds to nitrogen and potassium status; high light intensity and heat treatments reduce content, apparently through loss of capsaicin synthase and phenylalanine ammonia-lyase activity, while salt and water stress increase it ^{8Reference 8Uarrota VG et al. · 2021ReviewFactors affecting the capsaicinoid profile of hot peppers and biological activity of their non-pungent analogs (capsinoids) present in sweet peppersView study →}. Non-pungent sweet peppers make capsinoids (capsiate and relatives) instead, the difference tracing to loss of function in the aminotransferase gene pAMT ^{8Reference 8Uarrota VG et al. · 2021ReviewFactors affecting the capsaicinoid profile of hot peppers and biological activity of their non-pungent analogs (capsinoids) present in sweet peppersView study →}.

Prevalence in Nature

Dihydrocapsaicin occurs only in pungent Capsicum — it is not a general plant metabolite. It is present in every capsaicinoid-producing species examined, including C. annuum (cayenne, paprika-type and most culinary chillies), C. frutescens (tabasco), C. chinense (habanero and bonnet types), C. baccatum and C. pubescens ^{3Reference 3Antonious GF · 2006Screening Capsicum accessions for capsaicinoids contentView study →}.

Within the fruit it is concentrated in the placental tissue and dissepiment next to the seeds, not the flesh or the seeds themselves ^{7Reference 7Arce-Rodríguez ML · 2019ReviewBiochemistry and molecular biology of capsaicinoid biosynthesis: recent advances and perspectivesView study →}. Content is enormously variable: across 90 USDA germplasm accessions, total capsaicinoids ranged from undetectable to 11.2 mg per fruit, and the highest single dihydrocapsaicin figure was 2.3 mg/g fresh fruit in a C. frutescens accession ^{3Reference 3Antonious GF · 2006Screening Capsicum accessions for capsaicinoids contentView study →}. Even within one plant, individual fruits picked on the same day span a wide range of absolute content while holding a near-constant capsaicin:dihydrocapsaicin:nordihydrocapsaicin ratio ^{4Reference 4Kirschbaum-Titze P et al. · 2002Pungency in paprika (Capsicum annuum)View study →}.

The most concentrated everyday form is oleoresin capsicum — the solvent extract used in hot sauces, standardised supplements and self-defence sprays — in which capsaicin and dihydrocapsaicin are the two dominant analogues and pungency runs at roughly 15,000 Scoville heat units per microgram of total capsaicinoids ^{2Reference 2Reilly CA et al. · 2001Quantitative analysis of capsaicinoids in fresh peppers, oleoresin capsicum and pepper spray productsView study →}.

Major Natural Sources

Source	Part	What is documented
Cayenne and other Capsicum annuum chillies	fruit placenta	The mainstream culinary and herbal source; capsaicin usually dominant, dihydrocapsaicin second 3,29Reference 3Antonious GF · 2006Screening Capsicum accessions for capsaicinoids contentView study →Reference 29Mandal SK et al. · 2023ReviewCapsicum annuum L. and its bioactive constituents: a critical review of a traditional culinary spice in terms of its modern pharmacological potentials with toxicological issuesView study →
Tabasco pepper (C. frutescens)	fruit placenta	Highest recorded dihydrocapsaicin in a 90-accession screen (2.3 mg/g fresh fruit) 3Reference 3Antonious GF · 2006Screening Capsicum accessions for capsaicinoids contentView study →
Habanero / bonnet peppers (C. chinense)	fruit placenta	Highest recorded capsaicin accession; very high total capsaicinoids and Scoville values 1,3Reference 1Duelund L · 2017Contents of capsaicinoids in chillies grown in DenmarkView study →Reference 3Antonious GF · 2006Screening Capsicum accessions for capsaicinoids contentView study →
Aji peppers (C. baccatum)	fruit placenta	Capsaicinoid-producing; profile varies by accession 3Reference 3Antonious GF · 2006Screening Capsicum accessions for capsaicinoids contentView study →
Rocoto (C. pubescens)	fruit placenta	Capsaicinoid-producing; included in germplasm screens 3Reference 3Antonious GF · 2006Screening Capsicum accessions for capsaicinoids contentView study →
Oleoresin capsicum	solvent extract	Concentrated capsaicin + dihydrocapsaicin; the basis of hot sauces, standardised extracts and pepper sprays 2Reference 2Reilly CA et al. · 2001Quantitative analysis of capsaicinoids in fresh peppers, oleoresin capsicum and pepper spray productsView study →

Non-pungent sweet peppers and paprika-type cultivars carry the carotenoid pigments — capsanthin, capsorubin and β-carotene — with little or no capsaicinoid content ^{8Reference 8Uarrota VG et al. · 2021ReviewFactors affecting the capsaicinoid profile of hot peppers and biological activity of their non-pungent analogs (capsinoids) present in sweet peppersView study →}.

Discovery & Synthesis

The history here is really the history of capsaicin’s purification, and dihydrocapsaicin is what fell out of it. The pungent principle of Capsicum was pursued through the nineteenth century and named capsaicin; the structural and nomenclatural work that followed showed that the crystalline material chemists had been calling “capsaicin” was in fact the parent of a group of vanillyl fatty-acid amides, and that commercial capsaicin-labelled products were chemically heterogeneous — including the synthetic analogue nonivamide appearing as an adulterant ^{31Reference 31Cordell GA · 1993ReviewCapsaicin: identification, nomenclature, and pharmacotherapyView study →}. Dihydrocapsaicin was one of the members resolved in that process. A specific, well-attested first-isolation date for dihydrocapsaicin as a named individual compound was not found in the sources surveyed here; the honest statement is that it emerged from the twentieth-century resolution of capsaicinoids into distinct analogues rather than from a single discrete isolation event.

Manufacture today is by extraction from chilli fruit or by chemical synthesis ^{30Reference 30Muratovska N et al. · 2022ReviewTowards engineered yeast as production platform for capsaicinoidsView study →}. The amide is structurally simple — a vanillylamine plus a branched-chain fatty acid — so synthesis is straightforward, which is also why the wholly synthetic analogue nonivamide (pelargonic acid vanillylamide) circulates commercially and has been detected as a substitute in capsaicin-labelled material ^{31Reference 31Cordell GA · 1993ReviewCapsaicin: identification, nomenclature, and pharmacotherapyView study →}. A third route is under active development: transferring the capsaicinoid pathway into engineered Saccharomyces cerevisiae, with the aim of fermentative production from sugar and access to novel analogues ^{30Reference 30Muratovska N et al. · 2022ReviewTowards engineered yeast as production platform for capsaicinoidsView study →}. None of this is yet a commercial source of isolated dihydrocapsaicin; the compound reaches consumers almost entirely as part of a chilli or oleoresin mixture.

Patents: not yet researched.

Toxicity & Safety

Dihydrocapsaicin carries a low flag. It is consumed daily worldwide in gram-scale chilli intake with no signal of systemic toxicity, and the Capsicum annuum toxicology literature treats capsaicinoids as safe at culinary exposure ^{29Reference 29Mandal SK et al. · 2023ReviewCapsicum annuum L. and its bioactive constituents: a critical review of a traditional culinary spice in terms of its modern pharmacological potentials with toxicological issuesView study →}. The badge is low rather than negligible for three reasons: capsaicinoids are potent local irritants (this is the active principle of pepper spray), high oral doses cause real gastrointestinal burning, and the molecule has a documented CYP-mediated drug-interaction signal that most food constituents do not.

Safety at a Glance

✅ Low / no toxicity

• Culinary exposure is well tolerated. Dietary capsaicinoid intake has a long global track record; the compound is a normal component of chilli-containing food.
• Intensely irritating on contact. Eyes, broken skin and mucous membranes react strongly — dihydrocapsaicin is one of the two principal actives in oleoresin capsicum self-defence sprays, whose capsaicinoid concentration is poorly standardised between products and lots.
• CYP inhibition — a real interaction risk. Moderate inhibition of CYP1A2, 2C9, 2C19, 2D6 and 3A4/5 in human liver microsomes; in rats it raised efavirenz exposure ~2.5-fold. Relevant to high-dose capsaicinoid supplements rather than food.
• GI burning at high oral doses, and the usual caution in reflux, gastritis or active ulcer disease.
• Systemic (injected) dosing is a different drug. Parenteral dihydrocapsaicin lowers core temperature and heart rate in animals; bolus injection produced cardiovascular effects. Nothing about that profile has been tested in humans.

Full Safety & Interactions Detail

Local irritancy. Capsaicinoid pungency is TRPV1 activation on sensory nerve endings, so irritancy is inseparable from the molecule. Dihydrocapsaicin is, with capsaicin, one of the two dominant analogues in oleoresin capsicum, the basis of pepper sprays — and analysis of commercial products found capsaicinoid concentrations varying between manufacturers and between lots from a single manufacturer despite SHU labelling, which the authors flagged as a safety concern for users and subjects alike ^{2Reference 2Reilly CA et al. · 2001Quantitative analysis of capsaicinoids in fresh peppers, oleoresin capsicum and pepper spray productsView study →}. Practical consequence for anyone handling chilli or oleoresin: wash hands, avoid eyes and mucous membranes.

Drug interactions — the most underappreciated risk. Dihydrocapsaicin moderately inhibits CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4/5 in human liver microsomes, with IC₅₀ values of 4.4–61.8 µM and Kᵢ of 3.1–78.6 µM; CYP2E1 was largely spared (IC₅₀ > 200 µM). Inhibition was variously competitive, mixed and non-competitive, and repeated in-vivo dosing in rats induced CYP2E1 ^{12Reference 12Zhang QH et al. · 2012In vitroEffects of capsaicin and dihydrocapsaicin on human and rat liver microsomal CYP450 enzyme activities in vitro and in vivoView study →}. The clinical shape of that risk was demonstrated with the antiretroviral efavirenz: two weeks of 10 mg/kg/day dihydrocapsaicin in rats raised efavirenz AUC from ~8,800 to ~22,300 µg/mL·h, extended half-life, and cut clearance from 6.7 to 2.7 L/h/kg, with the same inhibition reproduced in liver microsomes ^{13Reference 13Wang B et al. · 2025In vitroImpact of dihydrocapsaicin on the metabolism of efavirenz in vitro and in vivo (rats)View study →}. This is an animal and in-vitro finding, not a documented human interaction — but it is a concrete reason to treat concentrated capsaicinoid supplements differently from chilli in food, particularly alongside narrow-therapeutic-index drugs cleared by CYP3A4, 2C9 or 2D6.

Gastrointestinal. High oral capsaicinoid doses cause epigastric and oesophageal burning; the effect is dose-related and local. Reviews of Capsicum annuum discuss the toxicological trade-offs of high intake alongside its pharmacological potentials ^{29Reference 29Mandal SK et al. · 2023ReviewCapsicum annuum L. and its bioactive constituents: a critical review of a traditional culinary spice in terms of its modern pharmacological potentials with toxicological issuesView study →}.

Route-dependent systemic effects. The rodent hypothermia literature is, read from a safety angle, a catalogue of what systemic dihydrocapsaicin does: core temperature falls by up to ~9 °C during cooling ^{17Reference 17Feketa VV et al. · 2013AnimalShivering and tachycardic responses to external cooling in mice are substantially suppressed by TRPV1 activation but not by TRPM8 inhibitionView study →}, heart rate drops ^{20Reference 20Mohammed M et al. · 2018AnimalActivation of TRPV1 in nucleus tractus solitarius reduces brown adipose tissue thermogenesis, arterial pressure, and heart rate (rats)View study →}, and bolus injection produced cardiovascular effects that infusion did not ^{19Reference 19He J et al. · 2016AnimalDihydrocapsaicin-induced hypothermia after asphyxial cardiac arrest in ratsView study →}. These are pharmacological doses by a parenteral route and do not describe dietary exposure — but they do mean high-dose systemic dihydrocapsaicin should not be assumed benign because chilli is.

Cytotoxicity caveat. In cell culture dihydrocapsaicin was more cytotoxic than capsaicin including in WI38 normal fibroblasts ^{24Reference 24Oh SH et al. · 2008In vitroDihydrocapsaicin (DHC), a saturated structural analog of capsaicin, induces autophagy in human cancer cells in a catalase-regulated manner (in vitro)View study →}, and it arrests global protein translation via HRI/eIF2α ^{28Reference 28De K et al. · 2022In vitroDihydrocapsaicin induces translational repression and stress granule through HRI-eIF2α phosphorylation axis (in vitro)View study →}. In-vitro cytotoxicity is therefore not tumour-selective in any demonstrated way.

Reproductive note (prose only). No dedicated reproductive- or developmental-toxicity dataset for isolated dihydrocapsaicin was identified. Pregnancy and lactation decisions belong to the herb or product page where intake is actually decided, not to a molecule page. Likewise no comprehensive isolate genotoxicity or repeat-dose toxicology package is characterised here beyond the capsaicinoid-class literature above.

Dosage

There is no established human dose for isolated dihydrocapsaicin, and no product supplies it as a single molecule. Supplements and standardised chilli extracts are labelled by total capsaicinoids, of which dihydrocapsaicin is a variable fraction — commonly cited around 20–40%, but ranging widely by cultivar ^{1,3Reference 1Duelund L · 2017Contents of capsaicinoids in chillies grown in DenmarkView study →Reference 3Antonious GF · 2006Screening Capsicum accessions for capsaicinoids contentView study →}. The figures below are research doses, listed so the numbers here are legible in context.

For context, the sensory absolute threshold for capsaicinoids in aqueous solution is well below a milligram per kilogram of food, so ordinary chilli-containing meals deliver far less than any of the doses above — and, given near-complete first-pass metabolism ^{10Reference 10Donnerer J et al. · 1990AnimalAbsorption and metabolism of capsaicinoids following intragastric administration in ratsView study →}, deliver almost none of it to the systemic circulation.

These are doses studied in research and are not a personal recommendation.

References

1. Duelund L, Mouritsen OG (2017). Contents of capsaicinoids in chillies grown in Denmark. Food Chemistry. https://pubmed.ncbi.nlm.nih.gov/27979294/
2. Reilly CA, Crouch DJ, Yost GS (2001). Quantitative analysis of capsaicinoids in fresh peppers, oleoresin capsicum and pepper spray products. Journal of Forensic Sciences. https://pubmed.ncbi.nlm.nih.gov/11372985/
3. Antonious GF, Jarret RL (2006). Screening Capsicum accessions for capsaicinoids content. Journal of Environmental Science and Health Part B. https://pubmed.ncbi.nlm.nih.gov/16785178/
4. Kirschbaum-Titze P, Mueller-Seitz E, Petz M (2002). Pungency in paprika (Capsicum annuum). 2. Heterogeneity of capsaicinoid content in individual fruits from one plant. Journal of Agricultural and Food Chemistry. https://pubmed.ncbi.nlm.nih.gov/11853515/
5. Govindarajan VS, Rajalakshmi D, Chand N (1987). Capsicum — production, technology, chemistry, and quality. Part IV. Evaluation of quality. A review. Critical Reviews in Food Science and Nutrition. https://pubmed.ncbi.nlm.nih.gov/3297498/
6. Ben-Chaim A, et al. (2006). QTL analysis for capsaicinoid content in Capsicum. Theoretical and Applied Genetics. https://pubmed.ncbi.nlm.nih.gov/16960715/
7. Arce-Rodríguez ML, Ochoa-Alejo N (2019). Biochemistry and molecular biology of capsaicinoid biosynthesis: recent advances and perspectives. A review. Plant Cell Reports. https://pubmed.ncbi.nlm.nih.gov/30941502/
8. Uarrota VG, Maraschin M, de Bairros ÂFM, Pedreschi R (2021). Factors affecting the capsaicinoid profile of hot peppers and biological activity of their non-pungent analogs (capsinoids) present in sweet peppers. A review. Critical Reviews in Food Science and Nutrition. https://pubmed.ncbi.nlm.nih.gov/32212928/
9. Chanda S, et al. (2008). In vitro hepatic and skin metabolism of capsaicin. Drug Metabolism and Disposition. https://pubmed.ncbi.nlm.nih.gov/18180272/
10. Donnerer J, Amann R, Schuligoi R, Lembeck F (1990). Absorption and metabolism of capsaicinoids following intragastric administration in rats. Naunyn-Schmiedeberg’s Archives of Pharmacology. https://pubmed.ncbi.nlm.nih.gov/2280802/
11. Kuzma M, et al. (2015). A validated HPLC-FLD method for analysis of intestinal absorption and metabolism of capsaicin and dihydrocapsaicin in the rat. Journal of Pharmaceutical and Biomedical Analysis. https://pubmed.ncbi.nlm.nih.gov/25462121/
12. Zhang QH, Hu JP, Wang BL, Li Y (2012). Effects of capsaicin and dihydrocapsaicin on human and rat liver microsomal CYP450 enzyme activities in vitro and in vivo. Journal of Asian Natural Products Research. https://pubmed.ncbi.nlm.nih.gov/22375877/
13. Wang B, et al. (2025). Impact of dihydrocapsaicin on the metabolism of efavirenz in vitro and in vivo (rats). Pharmacology Research & Perspectives. https://pubmed.ncbi.nlm.nih.gov/41286578/
14. Lorenzoni R, et al. (2019). Rapid and sensitive LC-MS/MS method for simultaneous quantification of capsaicin and dihydrocapsaicin in microdialysis samples following dermal application. Journal of Pharmaceutical and Biomedical Analysis. https://pubmed.ncbi.nlm.nih.gov/31129532/
15. Cao Z, Balasubramanian A, Marrelli SP (2014). Pharmacologically induced hypothermia via TRPV1 channel agonism provides neuroprotection following ischemic stroke when initiated 90 min after reperfusion (mice). American Journal of Physiology — Regulatory, Integrative and Comparative Physiology. https://pubmed.ncbi.nlm.nih.gov/24305062/
16. Feketa VV, et al. (2014). Transient receptor potential melastatin 8 channel inhibition potentiates the hypothermic response to transient receptor potential vanilloid 1 activation in the conscious mouse. Critical Care Medicine. https://pubmed.ncbi.nlm.nih.gov/24595220/
17. Feketa VV, et al. (2013). Shivering and tachycardic responses to external cooling in mice are substantially suppressed by TRPV1 activation but not by TRPM8 inhibition. American Journal of Physiology — Regulatory, Integrative and Comparative Physiology. https://pubmed.ncbi.nlm.nih.gov/24005250/
18. Cao Z, et al. (2017). TRPV1-mediated pharmacological hypothermia promotes improved functional recovery following ischemic stroke (mice). Scientific Reports. https://pubmed.ncbi.nlm.nih.gov/29247238/
19. He J, Young L, Jia X (2016). Dihydrocapsaicin-induced hypothermia after asphyxial cardiac arrest in rats. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. https://pubmed.ncbi.nlm.nih.gov/28268688/
20. Mohammed M, Madden CJ, Andresen MC, Morrison SF (2018). Activation of TRPV1 in nucleus tractus solitarius reduces brown adipose tissue thermogenesis, arterial pressure, and heart rate (rats). American Journal of Physiology — Regulatory, Integrative and Comparative Physiology. https://pubmed.ncbi.nlm.nih.gov/29590555/
21. Imaizumi K, et al. (2011). Capsaicinoids-induced changes of plasma glucose, free fatty acid and glycerol concentrations in rats. Journal of Toxicological Sciences. https://pubmed.ncbi.nlm.nih.gov/21297348/
22. Irandoost P, et al. (2021). The effect of capsaicinoids or capsinoids in red pepper on thermogenesis in healthy adults: a systematic review and meta-analysis. Phytotherapy Research. https://pubmed.ncbi.nlm.nih.gov/33063385/
23. Zsiborás C, et al. (2018). Capsaicin and capsiate could be appropriate agents for treatment of obesity: a meta-analysis of human studies. Critical Reviews in Food Science and Nutrition. https://pubmed.ncbi.nlm.nih.gov/28001433/
24. Oh SH, et al. (2008). Dihydrocapsaicin (DHC), a saturated structural analog of capsaicin, induces autophagy in human cancer cells in a catalase-regulated manner (in vitro). Autophagy. https://pubmed.ncbi.nlm.nih.gov/18818525/
25. Xie L, et al. (2016). Capsaicin and dihydrocapsaicin induce apoptosis in human glioma cells via ROS and Ca²⁺-mediated mitochondrial pathway (in vitro). Molecular Medicine Reports. https://pubmed.ncbi.nlm.nih.gov/27748914/
26. Shi S, et al. (2021). Dihydrocapsaicin inhibits cell proliferation and metastasis in melanoma via down-regulating β-catenin pathway (mice). Frontiers in Oncology. https://pubmed.ncbi.nlm.nih.gov/33833997/
27. Chen Y, et al. (2025). Dihydrocapsaicin attenuates oxidative stress and apoptosis in acute myocardial infarction via promoting Raf-1/ASK1 complex formation (rats). Phytomedicine. https://pubmed.ncbi.nlm.nih.gov/40768809/
28. De K, et al. (2022). Dihydrocapsaicin induces translational repression and stress granule through HRI-eIF2α phosphorylation axis (in vitro). Biochemical and Biophysical Research Communications. https://pubmed.ncbi.nlm.nih.gov/34953209/
29. Mandal SK, et al. (2023). Capsicum annuum L. and its bioactive constituents: a critical review of a traditional culinary spice in terms of its modern pharmacological potentials with toxicological issues. Phytotherapy Research. https://pubmed.ncbi.nlm.nih.gov/36255140/
30. Muratovska N, et al. (2022). Towards engineered yeast as production platform for capsaicinoids. A review. Biotechnology Advances. https://pubmed.ncbi.nlm.nih.gov/35623491/
31. Cordell GA, Araujo OE (1993). Capsaicin: identification, nomenclature, and pharmacotherapy. A review. Annals of Pharmacotherapy. https://pubmed.ncbi.nlm.nih.gov/8453173/

View all 31 references▾